Earnings call transcript: FinVolution Group misses Q4 2025 estimates

FinVolution reported Q4 EPS of $1.63 vs $2.19 consensus (-25.57% surprise) and revenue of $3.02bn vs $3.6bn expected (-16.11%), yet shares rose 5.73% after-hours to $5.54. Full-year 2025 revenue was RMB 13.6bn (+3.8% YoY) and net profit RMB 2.5bn (+6.6%); international revenue grew strongly (31% of Q4 revenue) and management executed $107m of buybacks in 2025 (chair/management added $1.9m), plus ~$74.5m dividends (50% payout). Management guided FY2026 group revenue to decline 5–15% YoY while targeting ~30% of 2026 revenue from international markets and pursuing the Fundo acquisition in Australia to accelerate developed-market expansion.

Analysis

FinVolution’s playbook is now two engines: a cash-generating mature market and a fast-scaling international platform. The acquisition route into a developed market (via an ACL-equipped lender) shortcuts regulatory lag but raises integration and funding-mix arbitrage questions — success depends on whether group-level funding differentials and risk models can be applied without material local adaptation costs.

Near-term deltas to watch are funding cost normalization and the trajectory of early delinquency metrics: improvements over a few months would unlock meaningful operating leverage in international cohorts and validate the “LEGO+” reuse of tech/risk assets; conversely, a renewed spike in domestic credit stress or an adverse new cap in a key SEA market will compress margins quickly. Currency and capital-allocation choices are a second-order lever — aggressive buybacks increase per-share upside if the international transition succeeds but reduce optionality to weather regulatory shocks.

Market pricing appears to bifurcate a near-term regulatory risk premium from a longer-term rerating on international scale. That creates a time-dependent trade: asymmetric upside if management executes cross-border playbook and converts higher-margin markets into a larger share of consolidated profit, against a concentrated downside if funding or regulatory friction forces equity raises. The fastest catalysts are evolving Philippines interest-rate rules and the next quarterly vintage-loss prints — both resolve on a months not years cadence.

Key Decisions for Investors

• Core position: Buy FINV equity sized to conviction (10–15% of regional fintech allocation) and hedge tail risk with a 6–9 month put (15% OTM). Rationale: captures re-rating if international revenue share continues to expand; hedge caps downside from a regulatory shock. Timeframe: 6–12 months. Risk/Reward: asymmetric — limited cost of hedge vs potential 2–3x upside on successful execution, put limits downside to ~-30–40%.
• Options spread: Buy a 12-month FINV call spread (ATM to +30% OTM) funded by selling a 3–6 month near-ATM call to monetize current premium. Rationale: exploits likely re-rating over a year while financing carry; roll short leg if early signs of execution persist. Timeframe: 9–12 months. Risk/Reward: capped upside but low net premium outlay; large positive skew if international growth meets guideposts.
• Relative trade: Pair long FINV / short a China-domestic-only consumer finance name (or ETF exposure) to isolate international-execution beta. Rationale: removes China-regulatory beta and isolates asset-redeployment payoff. Timeframe: 3–12 months. Risk/Reward: profitieren if FinVolution’s international scale outperforms domestic-only peers; risk if systemic China easing benefits all names equally.
• Tactical macro hedge: Increase exposure to AUD (via FX or short-duration AUD assets) sized to Fundo integration exposure while keeping FX hedge for SEA revenues. Rationale: protects USD-reported profit from AUD moves as Australian operations scale. Timeframe: rebalance over next 3–9 months.